← Evidence map

TrialBMC cancer2025

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial.

Xiao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40819029